192-IgG-SAP
Alzheimer's Disease Model (Cholinergic Neuron Ablation)
Research ToolActive
Key Facts
Indication
Alzheimer's Disease Model (Cholinergic Neuron Ablation)
Phase
Research Tool
Status
Active
Company
About Advanced Targeting Systems
Advanced Targeting Systems is a private biotechnology firm founded in 1994, commercializing a proprietary platform centered on the ribosome-inactivating toxin Saporin. The company creates targeted conjugates that bind to specific cell surface receptors, enabling researchers to selectively ablate cell populations to model diseases like Alzheimer's and Parkinson's and study cell functionality. While primarily serving the neuroscience research community, its tools have broad applicability across life sciences research and drug development. ATS operates as a reagent supplier and service provider, generating revenue through product sales and custom conjugate services.
View full company profile